SAM
ZBH icon

Symphony Asset Management’s Zimmer Biomet ZBH Stock Holding History

Symphony Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,130
Closed -$1.62M – 166
2019
Q4 		$1.62M Buy
11,130
+3
+0% +$414 0.36% 30
2019
Q3 		$1.48M Buy
11,127
+2,098
+23% +$271K 0.32% 36
2019
Q2 		$1.03M Sell
9,029
-588
-6% -$68.9K 0.22% 58
2019
Q1 		$1.19M Sell
9,617
-1,153
-11% -$131K 0.31% 40
2018
Q4 		$1.08M Buy
10,770
+289
+3% +$32.5K 0.32% 28
2018
Q3 		$1.34M Sell
10,481
-942
-8% -$112K 0.36% 33
2018
Q2 		$1.21M Sell
11,423
-24,015
-68% -$2.61M 0.24% 90
2018
Q1 		$3.75M Sell
35,438
-3,873
-10% -$450K 0.48% 48
2017
Q4 		$4.61M Buy
39,311
+233
+0.6% +$26.3K 0.47% 47
2017
Q3 		$4.44M Buy
39,078
+5,062
+15% +$584K 0.49% 49
2017
Q2 		$4.24M Buy
34,016
+971
+3% +$115K 0.48% 48
2017
Q1 		$3.92M Buy
33,045
+30,543
+1,221% +$3.46M 0.37% 58
2016
Q4 		$251K Buy
2,502
+21
+0.8% +$2.25K 0.03% 366
2016
Q3 		$313K Sell
2,481
-927
-27% -$115K 0.03% 338
2016
Q2 		$399K Sell
3,408
-36
-1% -$4.07K 0.04% 263
2016
Q1 		$356K Sell
3,444
-34
-1% -$3.29K 0.04% 296
2015
Q4 		$347K Sell
3,478
-18
-0.5% -$1.76K 0.04% 335
2015
Q3 		$319K Sell
3,496
-18
-0.5% -$1.8K 0.04% 373
2015
Q2 		$373K Sell
3,514
-24
-0.7% -$2.66K 0.05% 316
2015
Q1 		$404K Sell
3,538
-2,243
-39% -$256K 0.05% 374
2014
Q4 		$637K Hold
5,781
– – 0.08% 208
2014
Q3 		$564K Buy
+5,781
New +$569K 0.06% 232
2014
Q2 		– Sell
-4,308
Closed -$396K – 443
2014
Q1 		$396K Buy
4,308
+376
+10% +$34.7K 0.04% 340
2013
Q4 		$356K Buy
+3,932
New +$340K 0.03% 351

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Symphony Asset Management's ZBH Position: Q1 2020 in Review

Symphony Asset Management sold out of Zimmer Biomet (ZBH) in Q1 2020, closing a stake of 11,130 shares — an estimated $1.62M sold.

Symphony Asset Management first reported a position in ZBH in Q4 2013 and held it in 24 quarters. The position peaked at $4.61M in Q4 2017. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

  • Symphony Asset Management reported no remaining Zimmer Biomet position as of Q1 2020 after selling out during the quarter.
  • Symphony Asset Management sold 11,130 Zimmer Biomet shares in Q1 2020, an estimated $1.62M.
  • Symphony Asset Management first reported a position in Zimmer Biomet in Q4 2013 and held it in 24 quarters.
  • Symphony Asset Management's Zimmer Biomet position peaked at $4.61M in Q4 2017.
  • 883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on Symphony Asset Management's 13F filing for Q1 2020, filed 12 May 2020.